Not Signed In -
Heart Attack |
Acute Myocardial Infraction; Myocardial Infarction |
Clinical Trial: Study to Evaluate Potential Decrease in Hospitalization Events, Time between Events, and Increasing Longevity in Patients with Symptomatic Heart Failure
This study is currently recruiting patients.
|
Purpose
A multicenter study to evaluate potential decrease in hospitalization events and time between events and increasing longevity in patients with symptomatic congestive heart failure and intolerant of first-line medication for heart failure. This study will evaluate if higher doses of the investigational drug given daily will be superior to the lower dose of the same investigational drug given daily.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Heart Failure | | Phase IV |
MedlinePlus related topics: Cardiomyopathy
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: A Multicenter Study to Evaluate Potential Decrease in Hospitalization Events and Time between Events and Increasing Longevity in Patients with Symptomatic Heart Failure Intolerant of Standard Heart Failure Treatment
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Symptomatic heart failure with known or recently diagnosed intolerance of treatment with first-line medication for heart failure;
- May or may not be receiving an alternative and/or additional drug treatment.
Location and Contact Information
Pennsylvania
Call for International Site Information, Horsham, Pennsylvania, 19044, United States; Recruiting
More Information
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: August 25, 2004
ClinicalTrials.gov Identifier: NCT00090259
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- 9-1-1: Rapid Identification and Treatment of Acute MyocardialInfarction (National Heart, Lung, and Blood Institute Information Center, NHLBI, NIH, HHS)
- ACE Inhibitors after Heart Attacks: Varying Effects? (American College of Physicians)
email this page
print this page
bookmark this page
feedback on this page
